Filtered By Specialty: Service Category: Key Service: Region: Country:

Company Profiles1-10 of 213 Companies

Want to add your company?


Any question? Contact us!

Gesellschaft für Individualisierte Medizin mbH (IndyMED)

Logo Gesellschaft für Individualisierte Medizin mbH (IndyMED)
  • Pre-clinical development and testing, pre-clinical CRO
  • Europe

IndyMED is a young spin-off company that was founded in Rostock, Germany, in January 2004. This was supported by the Steinbeis Tranferzentrum Proteom-Analyse. More »

Stowers Institute for Medical Research

Logo Stowers Institute for Medical Research
  • Academic collaboration
  • North America

Our Mission To make a significant contribution to humanity through medical research by expanding our understanding of the secrets of life, and by improving life’s quality through innovative approaches to the causes, treatment and prevention of diseases.   More »

Vanderbilt University Medical Center (VUMC)

Logo Vanderbilt University Medical Center (VUMC)
  • Academic collaboration
  • Human Medicines
  • North America

The Center is a collection of several hospitals and clinics, as well as the schools of medicine and nursing. More »


  • Contract manufacturing, filling and packaging
  • Biopharmaceuticals
  • North America

Morphotek®, Inc., a subsidiary of Eisai Inc., is a biopharmaceutical company specializing in the development of protein and antibody products through the use of a novel and proprietary gene evolution technology.  The technology has been successfully applied to a broad variety of cell lines and organisms to yield genetically diverse offspring that are suitable for pharmaceutical product development in the areas of antibody therapeutics, protein therapeutics, product manufacturing, drug target discovery, and improved output traits for commercial applications.  The company is currently focusing its platform on the development and manufacturing of therapeutic antibodies for the treatment of cancer, inflammation and infectious disease. More »


Logo Abbiotec
  • Sourcing of APIs, Excipients, Intermediates, bulk drugs
  • Biopharmaceuticals
  • Europe, North America

The sequencing of the human genome is considered as one of the most important milestone of the century reached by the Life Science research community. Biologists have estimated the total number of genes at 25,000. Now, the annotated human genome sequence creates a range of new possibilities for biomedical research and permits a more systematic approach to proteomics. A concerted effort on the human proteome would certainly generate probes for identifying new targets for therapeutics. As researchers are focusing their efforts on determining the biological functions, interactions and regulation of the encoded proteins, the company is dedicated to developing cell biology-based research tools that assist scientific discoveries. More »

Prognosys Biosciences

Logo Prognosys Biosciences
  • Analytical laboratory and testing services
  • Biopharmaceuticals
  • North America

Prognosys Biosciences is a fast growing biotechnology company based in La Jolla, CA focused on the promising and rapidly developing field of personalized medicine. We are developing novel genomic and proteomic technologies to enable research discoveries and clinical applications. We have extensive expertise in the areas of assay development and biomarker discovery, as well as implementation of next-generation sequencing technologies for the analysis of complex biological systems. More »

GenxBio Health Sciences

Logo GenxBio Health Sciences
  • Pharmaceutical process development and validation
  • Biopharmaceuticals
  • Asia

GenxBio Health Sciences Pvt. Ltd  is one of the fastest growing biotech group in India that has successfully entered the clinical path /nanotechnology and pharmaceutical product development space. GenxBio was established to provide the most comprehensive product range in the fields of biotechnology, molecular biology, genomics, proteomics and pharmaceuticals sciences for the international and national Life Science R&D communities. GenxBio has been providing unparalleled service and support to our customers by combining technical expertise, quality material and sound business strategies. We have been growing dynamically towards our aim of becoming a leading supplier in the Asian continent. As we move forward we would like to reemphasize our commitment to quality, innovation and customer satisfaction and our utmost belief in helping our customers achieve their aims. More »


Logo NeoProteomics
  • Analytical laboratory and testing services
  • Biopharmaceuticals
  • North America

NeoProteomics' mission is to accelerate the process of drug and diagnostics development by providing innovative informatics solutions allowing clients to achieve biological understanding of their genomics and proteomics data at the systems level. Our solutions to customer problems provide fast and intuitive data analysis for assessing the structures of biologics and a navigable road map of the cell for understanding pharmaceutical drug targets, drug efficacy, and drug safety. More »

University of Exeter School of Biosciences

Logo University of Exeter School of Biosciences
  • Academic collaboration
  • Biopharmaceuticals
  • Europe

University of Exeter School of Biosciences offers bioinformatics, imaging, proteomic, and sequencing services. More »

Digilab (Maia Scientific)

Logo Digilab (Maia Scientific)
  • Analytical laboratory and testing services
  • Biopharmaceuticals
  • Europe, North America, Asia

Digilab has a rich history of technology and applications market leadership in spectrometry and photonics spanning over the past 40 years. Digilab was formed and was a pioneer in Fourier Transform InfraRed Spectroscopy. In the mid-1970's Digilab was sold to Bio-Rad Laboratories. In 2001, shortly after his retirement as President & CEO from Olympus America, Sidney Braginsky purchased Bio-Rad’s Molecular Spectroscopy Division and through his transaction all of the Digilab FTIR assets. Mr. Braginsky re-launched this business as Digilab LLC, leveraging this well appreciated global brand. Building upon Digilab's global brand loyalty, innovative products and customer service reputation, the company focused on advanced systems and solutions in the high growth life sciences research markets. Specifically, Digilab developed hardware and software features into its FTIR Focal Plane Array (FPA) Platform more than doubling placements of this solution. Additionally, Digilab's vision to be "Spectroscopy's Leading Light" led to strategic partnerships and investments designed to offer customers a broad range of molecular spectroscopy alternatives beyond FTIR, e.g. UV/Vis, NIR, and Raman. Importantly, a strategic partnership with Hitachi, providing exclusivity for the sale and servicing of Hitachi’s entire molecular spectroscopy product line in both Europe and North America, took Digilab’s installed instrument base from 5000 units to over 15,000 units. In September of 2004, Digilab sold its product assets to Varian Inc., Digilab, Inc invested the proceeds of this transaction in a business model focused principally on life science research tools and downstream point of need clinical, safety and security applications. In June of 2006, Digilab acquired SpectraCode Inc. in West Lafayette, Indiana. This acquisition provides Digilab core competence and products in high growth applications which require the versatility and ease of use of Raman Molecular Spectroscopy. More »

Page 1232122

Companies by service category

Companies by regionCompanies by specialty


Looking for special service?
Don't spend time on search!

Place Request Anonymously »

Get applications from providers For Free